Press Releases

Press Releases

February 17, 2022
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
CANTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today
Displaying 11 - 16 of 16


Shareholder Tools